Literature DB >> 15279634

The frequency of intratubular embryonal carcinoma: implications for the pathogenesis of germ cell tumours.

D M Berney1, A Lee, S J Randle, S Jordan, J Shamash, R T D Oliver.   

Abstract

AIMS: To define the frequency and distribution of intratubular embryonal carcinoma (IEC) in an attempt to shed light on the pathogenesis of non-seminomatous germ cell tumours (NSGCTs). Intratubular germ cell neoplasia of unclassified type (IGCNU) is common in NSGCT; however, IEC is rarely described. METHODS AND
RESULTS: Sixty-two germ cell tumours were reviewed. Immunochemistry for CD30, placental alkaline phosphatase (PLAP) and c-kit was performed. The distribution, immunohistochemistry and morphology of the intratubular neoplasia were noted. All cases showed widespread IGCNU with PLAP and c-kit staining. CD30 showed strong focal intratubular positivity in 20/31 NSGCTs, 1/29 seminomas and 1/4 mixed seminomas/NSGCTs. In 17 of these cases, the CD30+ tubules were not easily identified as IEC on routine stains. These tubules were scanty in number and c-kit was negative, though some showed patchy PLAP staining. The cells within these tubules differed morphologically from IGCNU.
CONCLUSIONS: IEC defined by CD30 positivity is not always easily identified on haematoxylin and eosin staining. We suggest that IEC is a common intermediate step between IGCNU and NSGCTs. The patchy and focal distribution of IEC suggests it may evolve quickly to invasive disease.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15279634     DOI: 10.1111/j.1365-2559.2004.01915.x

Source DB:  PubMed          Journal:  Histopathology        ISSN: 0309-0167            Impact factor:   5.087


  2 in total

Review 1.  Microinvasive germ cell tumor of the testis.

Authors:  Finn Edler von Eyben; Grete Krag Jacobsen; Rolf Inge Skotheim
Journal:  Virchows Arch       Date:  2005-06-21       Impact factor: 4.064

2.  Testicular germ cell tumors: the changing role of the pathologist.

Authors:  Andrea Ronchi; Francesca Pagliuca; Renato Franco
Journal:  Ann Transl Med       Date:  2019-09
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.